Skip to main content
. 2017 Nov 9;39(3):472–481. doi: 10.1038/aps.2017.153

Figure 2.

Figure 2

The pharmacokinetic and tumor growth data used for developing the PK/PD model. (A) Concentration-time curves of DEX after single or multiple doses at 8 mg/kg in nude mice (n=3). (B) Anti-cancer effects after different doses of DEX in MCF-7/Adr xenograft nude mice (n=5).